U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Links from MedGen

Items: 1 to 100 of 286

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh37:
Chr1:110173316-110173318
GRCh38:
Chr1:109630694-109630696
AMPD2E661del, E698del, E704del, E725del, E779delPontocerebellar hypoplasia type 9, not providedUncertain significance
(Sep 1, 2023)
criteria provided, multiple submitters, no conflicts
2.
GRCh37:
Chr1:110172960
GRCh38:
Chr1:109630338
AMPD2E633Q, E670Q, E676Q, E697Q, E751QHereditary spastic paraplegia 63, Pontocerebellar hypoplasia type 9not providedno assertion provided
3.
GRCh37:
Chr1:110172108
GRCh38:
Chr1:109629486
AMPD2R556S, R593S, R599S, R620S, R674SPontocerebellar hypoplasia type 9Likely pathogenic
(May 27, 2023)
criteria provided, single submitter
4.
GRCh37:
Chr1:108679275-111674176
Hereditary spastic paraplegia 63, Pontocerebellar hypoplasia type 9Pathogenic
(May 31, 2022)
criteria provided, single submitter
5.
GRCh37:
Chr1:110171370
GRCh38:
Chr1:109628748
AMPD2, LOC126805822V441I, V478I, V484I, V505I, V559IHereditary spastic paraplegia 63, Pontocerebellar hypoplasia type 9, Inborn genetic diseases
Uncertain significance
(Aug 21, 2023)
criteria provided, multiple submitters, no conflicts
6.
GRCh37:
Chr1:110171447
GRCh38:
Chr1:109628825
AMPD2, LOC126805822Hereditary spastic paraplegia 63, Pontocerebellar hypoplasia type 9Likely benign
(Sep 19, 2022)
criteria provided, single submitter
7.
GRCh37:
Chr1:110168422
GRCh38:
Chr1:109625800
AMPD2Hereditary spastic paraplegia 63, Pontocerebellar hypoplasia type 9Likely benign
(Sep 13, 2022)
criteria provided, single submitter
8.
GRCh37:
Chr1:110167953
GRCh38:
Chr1:109625331
AMPD2Hereditary spastic paraplegia 63, Pontocerebellar hypoplasia type 9Likely benign
(Sep 26, 2022)
criteria provided, single submitter
9.
GRCh37:
Chr1:110171331
GRCh38:
Chr1:109628709
AMPD2, LOC126805822R428C, R471C, R465C, R492C, R546CHereditary spastic paraplegia 63, Pontocerebellar hypoplasia type 9Uncertain significance
(Feb 23, 2022)
criteria provided, single submitter
10.
GRCh37:
Chr1:110169931
GRCh38:
Chr1:109627309
AMPD2D258N, D264N, D221N, D285N, D339NHereditary spastic paraplegia 63, Pontocerebellar hypoplasia type 9Uncertain significance
(Jun 14, 2022)
criteria provided, single submitter
11.
GRCh37:
Chr1:110173426
GRCh38:
Chr1:109630804
AMPD2Pontocerebellar hypoplasia type 9, Hereditary spastic paraplegia 63Likely benign
(May 24, 2022)
criteria provided, single submitter
12.
GRCh37:
Chr1:110169784
GRCh38:
Chr1:109627162
AMPD2Pontocerebellar hypoplasia type 9, Hereditary spastic paraplegia 63Likely benign
(Dec 7, 2021)
criteria provided, single submitter
13.
GRCh37:
Chr1:110167985
GRCh38:
Chr1:109625363
AMPD2A24V, A51V, A105VPontocerebellar hypoplasia type 9, Hereditary spastic paraplegia 63Uncertain significance
(Aug 1, 2022)
criteria provided, single submitter
14.
GRCh37:
Chr1:110173656
GRCh38:
Chr1:109631034
AMPD2G766D, G787D, G723D, G760D, G841DPontocerebellar hypoplasia type 9, Hereditary spastic paraplegia 63Uncertain significance
(Jun 23, 2022)
criteria provided, single submitter
15.
GRCh37:
Chr1:110171335
GRCh38:
Chr1:109628713
AMPD2, LOC126805822S493L, S466L, S429L, S547L, S472LHereditary spastic paraplegia 63, Pontocerebellar hypoplasia type 9Uncertain significance
(Jun 14, 2022)
criteria provided, single submitter
16.
GRCh37:
Chr1:110167984
GRCh38:
Chr1:109625362
AMPD2A105T, A24T, A51THereditary spastic paraplegia 63, Pontocerebellar hypoplasia type 9Uncertain significance
(May 4, 2022)
criteria provided, single submitter
17.
GRCh37:
Chr1:110173401
GRCh38:
Chr1:109630779
AMPD2G688C, G725C, G731C, G806C, G752CHereditary spastic paraplegia 63, Pontocerebellar hypoplasia type 9Uncertain significance
(Jun 24, 2022)
criteria provided, single submitter
18.
GRCh37:
Chr1:110172526
GRCh38:
Chr1:109629904
AMPD2Hereditary spastic paraplegia 63, Pontocerebellar hypoplasia type 9Likely benign
(May 27, 2022)
criteria provided, single submitter
19.
GRCh37:
Chr1:110169920
GRCh38:
Chr1:109627298
AMPD2R254H, R281H, R260H, R335H, R217HPontocerebellar hypoplasia type 9, Hereditary spastic paraplegia 63Uncertain significance
(May 4, 2022)
criteria provided, single submitter
20.
GRCh37:
Chr1:110173299
GRCh38:
Chr1:109630677
AMPD2Hereditary spastic paraplegia 63, Pontocerebellar hypoplasia type 9Likely benign
(Aug 11, 2022)
criteria provided, single submitter
21.
GRCh37:
Chr1:110171360
GRCh38:
Chr1:109628738
AMPD2, LOC126805822Hereditary spastic paraplegia 63, Pontocerebellar hypoplasia type 9Likely benign
(Jul 14, 2022)
criteria provided, single submitter
22.
GRCh37:
Chr1:110168985
GRCh38:
Chr1:109626363
AMPD2R92Q, R156Q, R210Q, R135Q, R129QHereditary spastic paraplegia 63, Pontocerebellar hypoplasia type 9Uncertain significance
(Apr 18, 2022)
criteria provided, single submitter
23.
GRCh37:
Chr1:110171391
GRCh38:
Chr1:109628769
AMPD2, LOC126805822P512S, P566S, P491S, P485S, P448SHereditary spastic paraplegia 63, Pontocerebellar hypoplasia type 9Uncertain significance
(Mar 11, 2022)
criteria provided, single submitter
24.
GRCh37:
Chr1:110168417
GRCh38:
Chr1:109625795
AMPD2Hereditary spastic paraplegia 63, Pontocerebellar hypoplasia type 9Uncertain significance
(Jun 10, 2022)
criteria provided, single submitter
25.
GRCh37:
Chr1:110168075
GRCh38:
Chr1:109625453
AMPD2Hereditary spastic paraplegia 63, Pontocerebellar hypoplasia type 9Likely benign
(Apr 8, 2022)
criteria provided, single submitter
26.
GRCh37:
Chr1:110173381
GRCh38:
Chr1:109630759
AMPD2R724H, R681H, R718H, R799H, R745HHereditary spastic paraplegia 63, Pontocerebellar hypoplasia type 9Uncertain significance
(Jun 19, 2022)
criteria provided, single submitter
27.
GRCh37:
Chr1:110169819
GRCh38:
Chr1:109627197
AMPD2Hereditary spastic paraplegia 63, Pontocerebellar hypoplasia type 9Likely benign
(Oct 24, 2022)
criteria provided, single submitter
28.
GRCh37:
Chr1:110168804
GRCh38:
Chr1:109626182
AMPD2R105W, R126W, R99W, R180W, R62WHereditary spastic paraplegia 63, Pontocerebellar hypoplasia type 9Uncertain significance
(Dec 15, 2021)
criteria provided, single submitter
29.
GRCh37:
Chr1:110163753
GRCh38:
Chr1:109621131
AMPD2R40WPontocerebellar hypoplasia type 9, Hereditary spastic paraplegia 63Uncertain significance
(Jan 16, 2022)
criteria provided, single submitter
30.
GRCh37:
Chr1:110169521
GRCh38:
Chr1:109626899
AMPD2Hereditary spastic paraplegia 63, Pontocerebellar hypoplasia type 9Likely benign
(Oct 19, 2022)
criteria provided, single submitter
31.
GRCh37:
Chr1:110173433
GRCh38:
Chr1:109630811
AMPD2Hereditary spastic paraplegia 63, Pontocerebellar hypoplasia type 9Likely benign
(Aug 10, 2022)
criteria provided, single submitter
32.
GRCh37:
Chr1:110173320
GRCh38:
Chr1:109630698
AMPD2E661K, E704K, E725K, E779K, E698KHereditary spastic paraplegia 63, Pontocerebellar hypoplasia type 9Uncertain significance
(May 26, 2022)
criteria provided, single submitter
33.
GRCh37:
Chr1:110169886
GRCh38:
Chr1:109627264
AMPD2R206C, R243C, R324C, R249C, R270CHereditary spastic paraplegia 63, Pontocerebellar hypoplasia type 9, Hereditary spastic paraplegia 63,
Pontocerebellar hypoplasia type 9, not provided
Uncertain significance
(Apr 11, 2023)
criteria provided, multiple submitters, no conflicts
34.
GRCh37:
Chr1:110170973
GRCh38:
Chr1:109628351
AMPD2, LOC126805822Hereditary spastic paraplegia 63, Pontocerebellar hypoplasia type 9Likely benign
(May 19, 2022)
criteria provided, single submitter
35.
GRCh37:
Chr1:110170803
GRCh38:
Chr1:109628181
AMPD2, LOC126805822Hereditary spastic paraplegia 63, Pontocerebellar hypoplasia type 9Likely benign
(Apr 12, 2022)
criteria provided, single submitter
36.
GRCh37:
Chr1:110163679
GRCh38:
Chr1:109621057
AMPD2C15SPontocerebellar hypoplasia type 9, Hereditary spastic paraplegia 63Uncertain significance
(May 8, 2022)
criteria provided, single submitter
37.
GRCh37:
Chr1:110168391
GRCh38:
Chr1:109625769
AMPD2Hereditary spastic paraplegia 63, Pontocerebellar hypoplasia type 9Likely benign
(Nov 23, 2021)
criteria provided, single submitter
38.
GRCh37:
Chr1:110163838
GRCh38:
Chr1:109621216
AMPD2, LOC129931109N37Y, K68I, K14IHereditary spastic paraplegia 63, Pontocerebellar hypoplasia type 9Uncertain significance
(Apr 28, 2022)
criteria provided, single submitter
39.
GRCh37:
Chr1:110169005
GRCh38:
Chr1:109626383
AMPD2R142W, R136W, R163W, R217W, R99WHereditary spastic paraplegia 63, Pontocerebellar hypoplasia type 9Uncertain significance
(Feb 23, 2022)
criteria provided, single submitter
40.
GRCh37:
Chr1:110171944
GRCh38:
Chr1:109629322
AMPD2, LOC126805822Hereditary spastic paraplegia 63, Pontocerebellar hypoplasia type 9Likely benign
(Mar 15, 2022)
criteria provided, single submitter
41.
GRCh37:
Chr1:110171362
GRCh38:
Chr1:109628740
LOC126805822, AMPD2R438H, R475H, R556H, R481H, R502HHereditary spastic paraplegia 63, Pontocerebellar hypoplasia type 9Uncertain significance
(Jul 25, 2022)
criteria provided, single submitter
42.
GRCh37:
Chr1:110163863
GRCh38:
Chr1:109621241
AMPD2, LOC129931109A45VHereditary spastic paraplegia 63, Pontocerebellar hypoplasia type 9Likely benign
(Jan 28, 2022)
criteria provided, single submitter
43.
GRCh37:
Chr1:110172888
GRCh38:
Chr1:109630266
AMPD2Q609E, Q646E, Q652E, Q727E, Q673EPontocerebellar hypoplasia type 9, Hereditary spastic paraplegia 63Uncertain significance
(Sep 27, 2022)
criteria provided, single submitter
44.
GRCh37:
Chr1:110170152
GRCh38:
Chr1:109627530
AMPD2Hereditary spastic paraplegia 63, Pontocerebellar hypoplasia type 9Likely benign
(Jan 15, 2022)
criteria provided, single submitter
45.
GRCh37:
Chr1:110169833
GRCh38:
Chr1:109627211
AMPD2P188L, P225L, P231L, P306L, P252LPontocerebellar hypoplasia type 9, Hereditary spastic paraplegia 63, Pontocerebellar hypoplasia type 9,
Hereditary spastic paraplegia 63, Inborn genetic diseases
Uncertain significance
(Apr 11, 2023)
criteria provided, multiple submitters, no conflicts
46.
GRCh37:
Chr1:110173022
GRCh38:
Chr1:109630400
AMPD2Hereditary spastic paraplegia 63, Pontocerebellar hypoplasia type 9Likely benign
(Jul 19, 2022)
criteria provided, single submitter
47.
GRCh37:
Chr1:110169390
GRCh38:
Chr1:109626768
AMPD2Hereditary spastic paraplegia 63, Pontocerebellar hypoplasia type 9Likely benign
(Aug 31, 2022)
criteria provided, single submitter
48.
GRCh37:
Chr1:110171039
GRCh38:
Chr1:109628417
AMPD2, LOC126805822Hereditary spastic paraplegia 63, Pontocerebellar hypoplasia type 9Likely benign
(Sep 8, 2022)
criteria provided, single submitter
49.
GRCh37:
Chr1:110169456
GRCh38:
Chr1:109626834
AMPD2R150C, R268C, R187C, R193C, R214CHereditary spastic paraplegia 63, Pontocerebellar hypoplasia type 9Uncertain significance
(Jul 20, 2022)
criteria provided, single submitter
50.
GRCh37:
Chr1:110170799
GRCh38:
Chr1:109628177
AMPD2, LOC126805822V371A, V392A, V328A, V365A, V446APontocerebellar hypoplasia type 9, Hereditary spastic paraplegia 63Uncertain significance
(Feb 8, 2022)
criteria provided, single submitter
51.
GRCh37:
Chr1:110173652
GRCh38:
Chr1:109631030
AMPD2V765M, V840M, V786M, V722M, V759MHereditary spastic paraplegia 63, Pontocerebellar hypoplasia type 9Uncertain significance
(Aug 22, 2022)
criteria provided, single submitter
52.
GRCh37:
Chr1:110170870
GRCh38:
Chr1:109628248
AMPD2, LOC126805822Pontocerebellar hypoplasia type 9, Hereditary spastic paraplegia 63Likely benign
(Oct 13, 2022)
criteria provided, single submitter
53.
GRCh37:
Chr1:110170797
GRCh38:
Chr1:109628175
LOC126805822, AMPD2Pontocerebellar hypoplasia type 9, Hereditary spastic paraplegia 63Likely benign
(Jun 29, 2022)
criteria provided, single submitter
54.
GRCh37:
Chr1:110168935
GRCh38:
Chr1:109626313
AMPD2Hereditary spastic paraplegia 63, Pontocerebellar hypoplasia type 9Likely benign
(Sep 1, 2022)
criteria provided, single submitter
55.
GRCh37:
Chr1:110168018
GRCh38:
Chr1:109625396
AMPD2R116H, R35H, R62HHereditary spastic paraplegia 63, Pontocerebellar hypoplasia type 9Uncertain significance
(May 27, 2022)
criteria provided, single submitter
56.
GRCh37:
Chr1:110170480
GRCh38:
Chr1:109627858
AMPD2, LOC126805822Hereditary spastic paraplegia 63, Pontocerebellar hypoplasia type 9Likely benign
(Oct 13, 2022)
criteria provided, single submitter
57.
GRCh37:
Chr1:110169516
GRCh38:
Chr1:109626894
AMPD2D234N, D170N, D207N, D213N, D288NPontocerebellar hypoplasia type 9, Hereditary spastic paraplegia 63Uncertain significance
(Mar 24, 2022)
criteria provided, single submitter
58.
GRCh37:
Chr1:110170541
GRCh38:
Chr1:109627919
AMPD2, LOC126805822Hereditary spastic paraplegia 63, Pontocerebellar hypoplasia type 9Likely benign
(Sep 3, 2022)
criteria provided, single submitter
59.
GRCh37:
Chr1:110173042-110173043
GRCh38:
Chr1:109630420-109630421
AMPD2Hereditary spastic paraplegia 63, Pontocerebellar hypoplasia type 9Likely benign
(Jun 4, 2022)
criteria provided, single submitter
60.
GRCh37:
Chr1:110171075
GRCh38:
Chr1:109628453
AMPD2, LOC126805822Hereditary spastic paraplegia 63, Pontocerebellar hypoplasia type 9Likely benign
(May 27, 2022)
criteria provided, single submitter
61.
GRCh37:
Chr1:110172111
GRCh38:
Chr1:109629489
AMPD2R557G, R594G, R621G, R675G, R600GHereditary spastic paraplegia 63, Pontocerebellar hypoplasia type 9Uncertain significance
(Apr 16, 2022)
criteria provided, single submitter
62.
GRCh37:
Chr1:110172884
GRCh38:
Chr1:109630262
AMPD2Hereditary spastic paraplegia 63, Pontocerebellar hypoplasia type 9Likely benign
(Apr 21, 2022)
criteria provided, single submitter
63.
GRCh37:
Chr1:110163703
GRCh38:
Chr1:109621081
AMPD2L23PHereditary spastic paraplegia 63, Pontocerebellar hypoplasia type 9Uncertain significance
(May 6, 2022)
criteria provided, single submitter
64.
GRCh37:
Chr1:110167977
GRCh38:
Chr1:109625355
AMPD2Hereditary spastic paraplegia 63, Pontocerebellar hypoplasia type 9Likely benign
(May 16, 2022)
criteria provided, single submitter
65.
GRCh37:
Chr1:110172410-110172411
GRCh38:
Chr1:109629788-109629789
AMPD2Hereditary spastic paraplegia 63, Pontocerebellar hypoplasia type 9Benign
(Apr 13, 2022)
criteria provided, single submitter
66.
GRCh37:
Chr1:110171048
GRCh38:
Chr1:109628426
AMPD2, LOC126805822Hereditary spastic paraplegia 63, Pontocerebellar hypoplasia type 9Likely benign
(May 3, 2022)
criteria provided, single submitter
67.
GRCh37:
Chr1:110171257-110171270
GRCh38:
Chr1:109628635-109628648
AMPD2, LOC126805822Hereditary spastic paraplegia 63, Pontocerebellar hypoplasia type 9Likely pathogenic
(Oct 18, 2022)
criteria provided, single submitter
68.
GRCh37:
Chr1:110168070
GRCh38:
Chr1:109625448
AMPD2Pontocerebellar hypoplasia type 9, Hereditary spastic paraplegia 63Likely benign
(Sep 13, 2022)
criteria provided, single submitter
69.
GRCh37:
Chr1:110173044
GRCh38:
Chr1:109630422
AMPD2Hereditary spastic paraplegia 63, Pontocerebellar hypoplasia type 9Likely benign
(Jul 11, 2022)
criteria provided, single submitter
70.
GRCh37:
Chr1:110168023
GRCh38:
Chr1:109625401
AMPD2S64A, S118A, S37AHereditary spastic paraplegia 63, Pontocerebellar hypoplasia type 9Uncertain significance
(Sep 27, 2022)
criteria provided, single submitter
71.
GRCh37:
Chr1:110172075
GRCh38:
Chr1:109629453
AMPD2T545S, T582S, T663S, T588S, T609SHereditary spastic paraplegia 63, Pontocerebellar hypoplasia type 9Uncertain significance
(Jun 25, 2022)
criteria provided, single submitter
72.
GRCh37:
Chr1:110168380
GRCh38:
Chr1:109625758
AMPD2Q107*, Q43*, Q86*, Q161*, Q80*Hereditary spastic paraplegia 63, Pontocerebellar hypoplasia type 9Pathogenic
(Jun 11, 2022)
criteria provided, single submitter
73.
GRCh37:
Chr1:110163847
GRCh38:
Chr1:109621225
AMPD2, LOC129931109F17S, F71SPontocerebellar hypoplasia type 9, Hereditary spastic paraplegia 63Uncertain significance
(Aug 31, 2022)
criteria provided, single submitter
74.
GRCh37:
Chr1:110169901
GRCh38:
Chr1:109627279
AMPD2V211M, V329M, V248M, V254M, V275MHereditary spastic paraplegia 63, Pontocerebellar hypoplasia type 9Uncertain significance
(May 20, 2022)
criteria provided, single submitter
75.
GRCh37:
Chr1:110163751-110163752
GRCh38:
Chr1:109621129-109621130
AMPD2L16fsHereditary spastic paraplegia 63, Pontocerebellar hypoplasia type 9Pathogenic
(Mar 19, 2022)
criteria provided, single submitter
76.
GRCh37:
Chr1:110168377
GRCh38:
Chr1:109625755
AMPD2R106W, R160W, R42W, R79W, R85WHereditary spastic paraplegia 63, Pontocerebellar hypoplasia type 9Uncertain significance
(May 11, 2022)
criteria provided, single submitter
77.
GRCh37:
Chr1:110170770
GRCh38:
Chr1:109628148
AMPD2, LOC126805822Hereditary spastic paraplegia 63, Pontocerebellar hypoplasia type 9Likely benign
(May 3, 2022)
criteria provided, single submitter
78.
GRCh37:
Chr1:110171796
GRCh38:
Chr1:109629174
AMPD2, LOC126805822P482L, P525L, P600L, P519L, P546LHereditary spastic paraplegia 63, Pontocerebellar hypoplasia type 9Uncertain significance
(Jul 9, 2022)
criteria provided, single submitter
79.
GRCh37:
Chr1:110170450
GRCh38:
Chr1:109627828
AMPD2, LOC126805822Hereditary spastic paraplegia 63, Pontocerebellar hypoplasia type 9Benign
(Aug 16, 2022)
criteria provided, single submitter
80.
GRCh37:
Chr1:110168957
GRCh38:
Chr1:109626335
AMPD2G120R, G201R, G126R, G147R, G83RHereditary spastic paraplegia 63, Pontocerebellar hypoplasia type 9Uncertain significance
(May 6, 2022)
criteria provided, single submitter
81.
GRCh37:
Chr1:110170389
GRCh38:
Chr1:109627767
AMPD2, LOC126805822Hereditary spastic paraplegia 63, Pontocerebellar hypoplasia type 9Likely benign
(Aug 9, 2022)
criteria provided, single submitter
82.
GRCh37:
Chr1:110169329
GRCh38:
Chr1:109626707
AMPD2Hereditary spastic paraplegia 63, Pontocerebellar hypoplasia type 9Likely benign
(Aug 23, 2022)
criteria provided, single submitter
83.
GRCh37:
Chr1:110167983
GRCh38:
Chr1:109625361
AMPD2Hereditary spastic paraplegia 63, Pontocerebellar hypoplasia type 9Likely benign
(Oct 7, 2022)
criteria provided, single submitter
84.
GRCh37:
Chr1:110163878
GRCh38:
Chr1:109621256
AMPD2, LOC129931109L50PHereditary spastic paraplegia 63, Pontocerebellar hypoplasia type 9Likely benign
(Mar 18, 2022)
criteria provided, single submitter
85.
GRCh37:
Chr1:110170103
GRCh38:
Chr1:109627481
AMPD2V278I, V284I, V359I, V305I, V241IHereditary spastic paraplegia 63, Pontocerebellar hypoplasia type 9Uncertain significance
(May 4, 2022)
criteria provided, single submitter
86.
GRCh37:
Chr1:110171940
GRCh38:
Chr1:109629318
AMPD2, LOC126805822Pontocerebellar hypoplasia type 9, Hereditary spastic paraplegia 63Likely benign
(Sep 7, 2022)
criteria provided, single submitter
87.
GRCh37:
Chr1:110171382
GRCh38:
Chr1:109628760
AMPD2, LOC126805822V488M, V482M, V445M, V509M, V563MPontocerebellar hypoplasia type 9, Hereditary spastic paraplegia 63, Inborn genetic diseases,
Hereditary spastic paraplegia 63, Pontocerebellar hypoplasia type 9
Uncertain significance
(Apr 11, 2023)
criteria provided, multiple submitters, no conflicts
88.
GRCh37:
Chr1:110168013
GRCh38:
Chr1:109625391
AMPD2Hereditary spastic paraplegia 63, Pontocerebellar hypoplasia type 9Likely benign
(Jul 5, 2022)
criteria provided, single submitter
89.
GRCh37:
Chr1:110170528
GRCh38:
Chr1:109627906
AMPD2, LOC126805822Pontocerebellar hypoplasia type 9, Hereditary spastic paraplegia 63Uncertain significance
(Apr 3, 2022)
criteria provided, single submitter
90.
GRCh37:
Chr1:110168343
GRCh38:
Chr1:109625721
AMPD2Hereditary spastic paraplegia 63, Pontocerebellar hypoplasia type 9Likely benign
(Mar 30, 2022)
criteria provided, single submitter
91.
GRCh37:
Chr1:110173426
GRCh38:
Chr1:109630804
AMPD2Hereditary spastic paraplegia 63, Pontocerebellar hypoplasia type 9Likely benign
(Jul 9, 2022)
criteria provided, single submitter
92.
GRCh37:
Chr1:110163665
GRCh38:
Chr1:109621043
AMPD2Hereditary spastic paraplegia 63, Pontocerebellar hypoplasia type 9Likely benign
(Oct 16, 2022)
criteria provided, single submitter
93.
GRCh37:
Chr1:110170048
GRCh38:
Chr1:109627426
AMPD2Hereditary spastic paraplegia 63, Pontocerebellar hypoplasia type 9Uncertain significance
(Mar 29, 2022)
criteria provided, single submitter
94.
GRCh37:
Chr1:110170968
GRCh38:
Chr1:109628346
AMPD2, LOC126805822Pontocerebellar hypoplasia type 9, Hereditary spastic paraplegia 63Likely benign
(Jan 17, 2022)
criteria provided, single submitter
95.
GRCh37:
Chr1:110170782
GRCh38:
Chr1:109628160
AMPD2, LOC126805822Hereditary spastic paraplegia 63, Pontocerebellar hypoplasia type 9Likely benign
(May 19, 2022)
criteria provided, single submitter
96.
GRCh37:
Chr1:110170502
GRCh38:
Chr1:109627880
AMPD2, LOC126805822R289*, R326*, R332*, R353*, R407*Pontocerebellar hypoplasia type 9Likely pathogenic
(Sep 1, 2022)
criteria provided, single submitter
97.
GRCh37:
Chr1:110171403
GRCh38:
Chr1:109628781
AMPD2, LOC126805822W452R, W489R, W495R, W516RPontocerebellar hypoplasia type 9Uncertain significance
(May 4, 2022)
criteria provided, single submitter
98.
GRCh37:
Chr1:110168337
GRCh38:
Chr1:109625715
AMPD2Hereditary spastic paraplegia 63, Pontocerebellar hypoplasia type 9Likely benign
(Aug 9, 2022)
criteria provided, single submitter
99.
GRCh37:
Chr1:110173771
GRCh38:
Chr1:109631149
AMPD2Hereditary spastic paraplegia 63, Pontocerebellar hypoplasia type 9, not provided,
Pontocerebellar hypoplasia type 9, Hereditary spastic paraplegia 63
Benign/Likely benign
(May 1, 2023)
criteria provided, multiple submitters, no conflicts
100.
GRCh37:
Chr1:110170982
GRCh38:
Chr1:109628360
AMPD2, LOC126805822Hereditary spastic paraplegia 63, Pontocerebellar hypoplasia type 9Likely benign
(Oct 14, 2022)
criteria provided, single submitter
Format
Items per page
Sort by
Choose Destination